• Home
  • About Steve Woodruff
  • Contact
  • About Impactiviti

Impactiviti blog

Pharma needs? Ask Steve.

Feeds:
Posts
Comments
« Social Media – What’s the big deal?
After Hours 5_2 »

Pharma News 5_2

May 2, 2008 by Steve Woodruff

BMS to sell off ConvaTec – Drug developer Bristol-Myers Squibb Co. said Friday it will sell its would therapy and surgical care unit for $4.1 billion to two private equity firms…more

Big cutback/merger action at J&J – sales and marketing for Ortho Biotech and Centocor to join, 400 jobs to go – Johnson & Johnson yesterday notified employees it will consolidate the sales and marketing operations of two subsidiaries, Ortho Biotech and Centocor, leading to roughly 400 job cuts nationwide…more, and Pharmalot’s take here.

Big layoffs at Wyeth: another 1,200 – The drugmaker last Friday notified employees that still more jobs are going, a Wyeth spokesman confirms. This follows an announcement last month that 1,240 sales positions would be eliminated as part of what Wyeth execs are calling ‘Project Impact.’…more

Big expansion at FDA – The U.S. Food and Drug Administration aims to hire more than 1,300 biologists, chemists, pharmacologists and other staff members by October as part of a major expansion, the agency said on Wednesday…more

Pfizer makes a deal on some Bextra/Celebrex lawsuits – The drugmaker reached tentative settlements with some groups of plaintiffs who allege the painkillers caused heart attacks and strokes, The Wall Street Journal reports, citing lawyers at three firms involved in the litigation…more

Takeda’s Amitiza get IBS-C indication – The Food and Drug Administration on Tuesday approved the first U.S. drug to treat irritable bowel syndrome with constipation (IBS-C) in adult women, a medicine made by Takeda Pharmaceutical Co and Sucampo Pharmaceuticals Inc…more (this allows Amitiza to step into the void left by the withdrawal of Novartis’ Zelnorm last year)

Merck’s experimental cholesterol drug stumbles at FDA – U.S. health regulators have rejected Merck & Co Inc‘s new drug designed to raise the level of HDL, or “good” cholesterol, the company said on Monday, sending its shares down 5 percent…more

Wyeth bowel drug wins approval – Wyeth and Progenics Pharmaceuticals Inc won U.S. approval to sell a new drug to relieve the constipation that often occurs with use of morphine or other opioid painkillers, regulators said…more

Interesting potential avenue for HIV treatment – Researchers have pinpointed a protein in a key human immune system cells needed for the AIDS virus to infect them, and found that turning it off can greatly slow down the deadly virus…more

Wow. Just saw this (hat tip: Kevin MD). A doctor who gives up his practice in California to help people in Tanzania. Very moving. I know someone who recently gave up his practice in Michigan to do medical mission work in Togo, and the stories are similar…

About these ads

Share this:

  • Twitter
  • StumbleUpon
  • Facebook
  • Email

Like this:

Like Loading...

Posted in Biotech, J&J, Johnson and Johnson, Medicine, Merck, Pfizer, Takeda, Wyeth | Tagged amitiza, Centocor, IBS-C, ortho biotech, Progenics |

  • Welcome!


    Steve Woodruff
    sw
    President, Impactiviti
    Pharmaceutical Connection Agent
  • Connect with Steve Woodruff


    SteveWoodruff.com
  • Testimonials


    “Steve Woodruff is one of the most “networked” people I’ve found in pharmaceutical training. His communications are always smart and targeted, and I value his professional partnership.” -Jennifer Zinn, Director, Worldwide Marketing, Clinical Laboratory, Ortho Clinical Diagnostics

    Read More Testimonials
  • Free ebook! Getting Started with Social Networking

  • Subscribe!

    Subscribe in a reader
  • Subscribe via e-mail

    Subscribe to Impactiviti blog by Email
  • Subscribe to our e-newsletter

    View our Archive
    Email Marketing by Constant Contact®

  • Bookmark



  • Recent Posts

    • Is Pharma Sales Dead?
    • We Do Everything…Just Like Everybody Else!
    • Create Your Vendor Map
    • Create Your Vendor Funnel
    • Friday Notes 3_8_13
    • Fresh Job Postings
    • On Writing Well
    • Let’s Talk
    • Successful Vendor Management – Measuring Success
    • Successful Vendor Management – Define Your Terms
  • Recent Comments

    Glen Drummond on Is Pharma Sales Dead?
    Andrew Nemiccolo (@n… on Is Pharma Sales Dead?
    DenVan on We Do Everything…Just Li…
    Steve Woodruff (@swo… on We Do Everything…Just Li…
    Steve Woodruff (@swo… on We Do Everything…Just Li…
  • Archives

    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • July 2012
    • June 2012
    • May 2012
    • April 2012
    • March 2012
    • February 2012
    • January 2012
    • December 2011
    • November 2011
    • October 2011
    • September 2011
    • August 2011
    • July 2011
    • June 2011
    • May 2011
    • April 2011
    • March 2011
    • February 2011
    • January 2011
    • December 2010
    • November 2010
    • October 2010
    • September 2010
    • August 2010
    • July 2010
    • June 2010
    • May 2010
    • April 2010
    • March 2010
    • February 2010
    • January 2010
    • December 2009
    • November 2009
    • October 2009
    • September 2009
    • August 2009
    • July 2009
    • June 2009
    • May 2009
    • April 2009
    • March 2009
    • February 2009
    • January 2009
    • December 2008
    • November 2008
    • October 2008
    • September 2008
    • August 2008
    • July 2008
    • June 2008
    • May 2008
    • April 2008
    • March 2008
    • February 2008
    • January 2008
    • December 2007
    • November 2007
    • October 2007
    • September 2007
    • August 2007
    • July 2007
    • June 2007
    • May 2007
    • April 2007
    • March 2007
    • February 2007
    • January 2007
    • December 2006
    • November 2006
    • October 2006
    • September 2006
    • August 2006
    • July 2006
  • Categories

    • Abbott
    • Advertising
    • After Hours
    • Allergan
    • Amgen
    • Amylin
    • Assessment
    • AstraZeneca
    • Avandia
    • Bayer
    • Biotech
    • Blogging
    • Blogs
    • BMS
    • Boehringer Ingelheim
    • book review
    • Branding
    • Bristol Myers
    • Business
    • Career planning
    • Celgene
    • Cephalon
    • Communications
    • Conference
    • Consulting
    • Covidien
    • Daiichi Sankyo
    • Depression
    • Diabetes
    • DTC
    • eLearning
    • Eli Lilly
    • Entrepreneur
    • ePatients
    • epharma
    • Ethics
    • facebook
    • FDA
    • Forest Labs
    • Friday Collection
    • Fun
    • Genentech
    • Genzyme
    • Glaxosmithkline
    • GSK
    • Healthcare
    • Impactiviti
    • Inspiration
    • Interview
    • iPad
    • J&J
    • Job
    • Job Board
    • John Mack
    • Johnson and Johnson
    • Lilly
    • Marketing
    • Medical Devices
    • Medicine
    • Meetings
    • Merck
    • Mobile
    • Music
    • Musings
    • Networking
    • News
    • No Bad Training
    • Novartis
    • Novo Nordisk
    • Obesity
    • Oncology
    • Outsourcing
    • Parenting
    • Paul Potts
    • Personal
    • Peter Rost
    • Pfizer
    • Pharma
    • Pharma News
    • Pharmaceutical
    • Project Management
    • Purdue
    • Recommendations
    • Red Cross
    • Reviews
    • Right-sourcing
    • Roche
    • Sales
    • Sales training
    • Sanofi-Aventis
    • Scandal
    • Schering
    • Social Media
    • SPBT
    • Spoof
    • Starting a business
    • Statins
    • Takeda
    • Technology
    • The Pharma Side
    • Top News
    • Training
    • Training Needs
    • Twitter
    • Uncategorized
    • Vendor Management
    • Vendor Selection
    • Video
    • Web
    • Webinar
    • Wyeth
    • Wyth
  • Add to Technorati Favorites
    Alltop, all the top stories
  • Pages

    • About Impactiviti
    • About Steve Woodruff
    • Contact

Blog at WordPress.com.

Theme: MistyLook by WPThemes.


Follow

Get every new post delivered to your Inbox.

Powered by WordPress.com
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: